Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer

被引:41
|
作者
Traina, Tiffany A.
Norton, Larry
Drucker, Karen
Singh, Buvanesh
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA
来源
ONCOLOGIST | 2006年 / 11卷 / 10期
关键词
D O I
10.1634/theoncologist.11-10-1070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1070 / 1071
页数:2
相关论文
共 50 条
  • [21] Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
    Bisgin, Atil
    Kargi, Aysegul
    Yalcin, Arzu D.
    Aydin, Cigdem
    Ekinci, Deniz
    Savas, Burhan
    Sanlioglu, Salih
    BMC CANCER, 2012, 12
  • [22] Esophageal perforation in a patient with metastatic breast cancer to esophagus
    Anaya, DA
    Yu, MJ
    Karmy-Jones, R
    ANNALS OF THORACIC SURGERY, 2006, 81 (03): : 1136 - 1138
  • [23] Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer
    Ruiz, Nuria
    Fernandez-Martos, Carlos
    Romero, Ignacio
    Pla, Angel
    Maiquez, Joaquin
    Calatrava, Ana
    Guillem, Vicente
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3376 - 3377
  • [24] Nasal septum perforations: A side effect of the association of bevacizumab and taxanes in patients with breast cancer?
    Mailliez, A.
    Baldini, C.
    Servent, V.
    Mallet, Y.
    Dewas, S.
    Bonneterre, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Intestinal perforation due to metastases of breast carcinoma in a patient treated by bevacizumab and paclitaxel
    Mychaluk, J.
    Fauvet, R.
    Edou-Abessolo, C.
    Ameslant, S.
    Merviel, P.
    Andrejak, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 69 - 69
  • [26] RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
    Nicolazzo, Chiara
    Belardinilli, Francesca
    Vestri, Annarita
    Magri, Valentina
    De Renzi, Gianluigi
    De Meo, Michela
    Caponnetto, Salvatore
    Di Nicolantonio, Federica
    Cortesi, Enrico
    Giannini, Giuseppe
    Gazzaniga, Paola
    CANCERS, 2022, 14 (03)
  • [27] Breast Cancer Subtype and Survival in Metastatic Patients Treated With Bevacizumab
    Torrejon Castro, D.
    Di Cosimo, S.
    Vidal, M.
    Gomez, P.
    Bellet, M.
    Saura, C.
    Perez-Garcia, J.
    Munoz, E.
    Baselga, J.
    Cortes, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S349 - S349
  • [28] Nasal septum perforation: Initial presentation in a patient with rheumatoid arthritis
    El Biaz, Samar
    Naji, Youssef
    Tijani, Adil
    Aderdour, Lahcen
    Raji, Abdelaziz
    Essaadouni, Lamia
    PRESSE MEDICALE, 2010, 39 (09): : 982 - 983
  • [29] CHRONIC EMPYEMA IN A PATIENT WITH METASTATIC BREAST CANCER ON BEVACIZUMAB TREATMENT
    Yoshimura, Noriko
    Kawabuchi, Yoshiharu
    Kondo, Tomohiro
    ANNALS OF ONCOLOGY, 2014, 25
  • [30] VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis
    Lucas Vieira dos Santos
    Marcelo Rocha Cruz
    Gilberto de Lima Lopes
    Joao Paulo da Silveira Nogueira Lima
    Breast Cancer Research and Treatment, 2015, 151 : 481 - 489